The only numeric estimate for penetrance for p.Val804Met published to date has been from Rich et al. (28), who report penetrance of RET p.Val804Met for MTC to age 70 as 87% (95% CI, 71% to 94%), with the median age of detection of MTC at 54 years. Here, RET is linked to medullary thyroid gland carcinoma.